This New Jersey Senate resolution (SR 50) urges Congress to pass the federal "Black Maternal Health Momnibus Act," a legislative package of 13 bills. The resolution highlights that Black women in the U.S. are three times more likely to die from pregnancy-related causes than white women, with maternal mortality rates remaining highest among Black mothers. The Momnibus Act would allocate over $1 billion to address racial disparities by funding support for basic needs (like housing and transportation), expanding mental health and substance use services, improving data collection, and increasing access to care through telehealth. The resolution does not create new law but calls for federal action to reduce preventable maternal deaths.
This New Jersey bill (S 494) requires health insurance plans that cover cancer chemotherapy to also cover scalp cooling systems. These systems are devices used to prevent hair loss during chemotherapy treatment. The law applies to all major insurance types (including individual, group, employer-sponsored, and hospital service plans) that already cover chemotherapy, mandating coverage "to the same extent as for any other condition." It directly affects insurers, who must provide this coverage, and cancer patients, who gain access to a therapy that may reduce treatment-related hair loss.
SJR 31 establishes the New Jersey Pharmacogenomics Commission to study how a person's genetic makeup affects medication effectiveness and safety (pharmacogenomics). The 13-member commission, appointed by the Governor and legislative leaders, will examine costs, benefits for patients and providers, applications like opioid crisis response, and potential reductions in adverse drug events. It must hold public hearings in northern and southern New Jersey within six months of forming and submit a final report to the Governor and Legislature within six months of its organization. The commission expires after submitting this report, which will inform potential future policy decisions. This is a study commission only - no new laws or funding are created by the bill.
This bill (S 2776) requires certain firms that place caregivers for non-medical home services to register as "Health Care Service Firms" with New Jersey's Division of Consumer Affairs. It directly affects employment agencies and similar businesses that arrange companion, health care, or personal care services for people with disabilities or those aged 60+ in their homes - excluding licensed home health or hospice agencies. Key provisions include mandating accreditation within 12 months of registration, requiring annual financial reports, and imposing tiered audit requirements based on firm revenue (e.g., firms earning over $5 million in Medicaid funds must submit audits every three years). The bill aims to increase oversight of these providers through standardized financial and operational reporting.
This bill requires that medication in group homes, supervised apartments, and day programs serving people with developmental disabilities must be given only by nurses or certified medication aides working under a nurse's direct supervision. It mandates that parents or legal guardians must provide detailed medication instructions to facility nurses whenever a resident's medication or dosage changes. The bill defines key terms like "community-based residential program" (including group homes and supervised apartments) and "day program" to clarify which facilities it covers. It applies directly to residential facilities licensed by New Jersey's Department of Human Services and their staff, as well as families managing their loved ones' care. The policy aims to standardize medication safety without creating new programs or funding.
This bill requires health insurance companies and other health carriers in New Jersey to reimburse healthcare providers for vaccines at a rate no lower than the Centers for Disease Control and Prevention (CDC) cost per dose rate listed on the CDC's official price list. It directly affects health insurance carriers (including companies and health plans) and healthcare providers who administer vaccines. The key provision sets a minimum reimbursement rate based on the CDC's actual per-dose cost effective on the date the vaccine was provided. This ensures providers are paid at least the CDC's contracted price, preventing underpayment for vaccine administration.
S 1302 creates two bodies to address veteran support in New Jersey. A 13-member task force will study issues faced by service members returning from Afghanistan/Iraq deployments (including mental health, employment, and family needs) and recommend state actions. A separate 5-member commission will review inconsistent state definitions of "veteran" and "disabled veteran" to improve clarity and uniformity. Both groups must issue reports with findings and legislative recommendations within six months. The bill directly affects returning National Guard members, reservists, and their families, focusing on practical support systems rather than new benefits.
This bill, S 2753, would expand New Jersey’s NJ FamilyCare health coverage program to include pregnant undocumented immigrants and their dependent children under age one. Pregnant undocumented immigrants would receive full coverage through the 60 days following their pregnancy, and their children would qualify for coverage until age one - bypassing current rules that limit undocumented immigrants to emergency-only care. The bill requires the state to first seek federal funding for this coverage, and if federal funds aren’t approved, it would rely on state funds. It explicitly states coverage would only be provided in compliance with federal law, defining "undocumented immigrant" as someone unable to verify legal status or lawful presence in the U.S.
S 1554, "Breann's Law," requires health insurers, the State Health Benefits Program (SHBP), and NJ FamilyCare to cover out-of-network medical services for children diagnosed with catastrophic illnesses. It applies when an in-network provider refers the child for care, and coverage must match what's provided for in-network services under the same plan. The bill defines "catastrophic illness" as life-threatening or causing serious disability, and covers dependent children under specific insurance contracts. This policy change directly affects families with children facing severe medical conditions and the insurers managing their health coverage.
S 299 establishes New Jersey's Blue Band Program to reduce preventable maternal deaths linked to preeclampsia (a pregnancy condition involving high blood pressure). The bill requires the Department of Health's Office of Maternal and Child Health to implement a program where hospitals and federally qualified health centers provide blue wristbands to pregnant or postpartum individuals identified as at risk for preeclampsia. These visible wristbands alert all healthcare providers across appointments and care settings about the patient's condition, improving coordination during critical postpartum periods. The program includes developing educational materials, tracking participation through annual reports, and aims to reduce maternal mortality by enhancing early detection and follow-up care. It directly affects at-risk pregnant and postpartum individuals in New Jersey, with hospitals voluntarily participating in the initiative.
